News

Novo Nordisk manufactures much of its GLP-1 drugs in Denmark. The president delayed implementation of the tariff over the ...
Novo Nordisk should perform well thanks to new leadership and a strong underlying business. Exelixis' main oncology franchise ...
Abbott published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless pacemaker (LP) ...
Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...
HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...
The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...
Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
"Being linked to 'Ozempic face' inducing changes to the mouth, teeth, gums and surrounding facial structures due to the rapid ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.